Contraline Capsule, a series of FundRx Master Fund I, LLC — Form D
Contraline Capsule, a series of FundRx Master Fund I, LLC of New York, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-05-05. The offering totals $290K, of which $290K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-05-05
- Form: D
- Accession: 0001793999-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C.1
- Total offering: $290K
- Amount sold: $290K
- Minimum investment: $5K
- Investors: 13
- Date of first sale: 2020-05-01
- Security types: fund interests
- SEC file number: 021-366272
Issuer
- Name: Contraline Capsule, a series of FundRx Master Fund I, LLC
- CIK: 0001793999
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 43 W 23rd St, New York, NY, 10010
- Phone: (352) 346-8957
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| LLC FundRx Capital Management, | Director | New York, NY |
| Jeremy Neilson | Executive Officer | Salt Lake City, UT |
| Richard Thoms | Executive Officer | Salt Lake City, UT |
More